322,834 research outputs found
Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis
No full textNon-alcoholic fatty liver disease comprises a spectrum of diseases ranging from simple steatosis to non-alcoholic steatohepatitis, fibrosis, and cirrhosis. Probiotics have been proposed as a treatment option because of their modulating effect on the gut flora that could influence the gut-liver axis.However, the lack of randomised clinical trials makes it impossible to support or refute probiotics for patients with non alcoholic fatty liver disease and non-alcoholic steatohepatitis
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
No full textNon-alcoholic fatty liver disease (NAFLD) is characterised by fatty deposition in the hepatocytes of patients with minimal or no alcohol intake and without ther known cause. NAFLD include a wide spectrum of histologic abnormalities ranging from hepatic steatosis to non-alcoholic steatohepatitis (NASH), or even cirrhosis. Antioxidant supplements, therefore, could potentially protect cellular structures against oxidative stress and the resulting lipid peroxidation. There is insufficient data to either support or refute the use of antioxidant supplements for patients with NAFLD. It may be advisable to carry out large prospective randomised clinical trials on this topic
Divi Ioan//nis Chrisostomi// De Modo Orando (!)// Deum, Libri duo
No full textEras-//mo Rot. interpreteVorlageform des Erscheinungsvermerks: Godefridus Tzuuyuel// excudebat. Anno ... - Druckermarke: Gotfridvs ZwivelivsEnth.: De modo orando deum liber primus . - De precatione liber secundusHaller. Buchdruck Münsters. Nr. 72Bömer. Münsterische Buchdruck S. 67, Nr. 6 (II
Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis.
No full textNon-alcoholic fatty liver disease is a condition charactrerised by fatty deposition in the hepatocytes of patients with minimal or no alcohol intake. Some patients develop non alcoholic steatohepatitis. Bile acids may potentially protect cellular structures and may be of benefit in patients with non alcoholic fatty liver or steatohepatitis.Presently, there are insufficient data to support or refute the use of ursodeoxycholic acid for patients with non-alcoholic fatty liver or steatohepatitis. It may be advisable to carry out large randomised clinical trials on this topic
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis (Protocol)
No full textThe Cochrane Collaboration Published by John Wiley & Sons, Ltd
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis. (Protocol)
No full textThe Cochrane Collaboration
Published by John Wiley & Sons, Ltd
The perihepatic adipose tissue thichness: a non-invasive marker of NAFLD?
No full textSeveral non-invasive markers have been proposed to assess liver damage in NAFLD. We measured by ultrasound (US) the perihepatic adipose tsssue thickness (PATT), i.e. the thickness of the fat between the abdominal muscular layer and the hepatic surface, in addition to waist circumference, BMI, biochemistry and serum adipokines, to predict the severity of liver damage in NAFLD. In conclusion PATT and waist circumference could represent non- invasive markers predicting the severity of liver damage in NAFLD
Diffusive author(s), cohesive author: Analysis of S/N (1994)
No full textThis study indicates the ways in which various aspects of the author(s) are brought forth in Dumb type’s performance art, the S/N production. Previous research has suggested a non-hierarchical organization of Dumb type and the absence of a “privileged author” in Dumb type’s collaborative work, S/N. However, the results that I have investigated from member’s interviews on the creative process of S/N along with my analysis of the recorded images of S/N, indicate a different aspect of the author(s). First, S/N was created through, so to speak, the collective ideas of the members of Dumb type. Further, S/N has at least nine quotations from previous performances, installations, and printed writings, besides the work-in-progress technique. Explicating one of the “author functions” as given by Michel Foucault, each text has plural subjects of the author. However, it has been revealed from members’ interviews that Teiji Furuhashi had a decision-making role in selecting the members’ ideas within the performance. Since then, S/N has had plural subjects of creation; however, Furuhashi is one of the subjects of creation along with the “privileged author.” S/N has plural authors (diffusive authors) yet at the same time, it has a “privileged author,” Teiji Furuhashi (cohesive author)
- …
